Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX)

CUSIP: 00430H102

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
27,795,576
Total 13F shares
24,494,123
Share change
-1,031,682
Total reported value
$17,145,621
Put/Call ratio
376%
Price per share
$0.70
Number of holders
64
Value change
-$735,427
Number of buys
19
Number of sells
27

Quarterly Holders Quick Answers

What is CUSIP 00430H102?
CUSIP 00430H102 identifies AXDX - Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) as of Q1 2023

As of 31 Mar 2023, Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) was held by 64 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,494,123 shares. The largest 10 holders included GRIFFIN ASSET MANAGEMENT, INC., VANGUARD GROUP INC, Birchview Capital, LP, ORACLE INVESTMENT MANAGEMENT INC, Alyeska Investment Group, L.P., Cannell & Co., BlackRock Inc., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and Cladis Investment Advisory, LLC. This page lists 64 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.